Methods of providing solriamfetol therapy to subjects with impaired renal function | Patent Number 11850228

US 11850228 B2
Application Number18295114
Publication NumberUS 20230263764 A1
Pendency8 months, 27 days
Filled DateApr 3, 2023
Priority DateMar 19, 2020
Publication DateAug 24, 2023
Expiration DateMar 18, 2040
Inventor/ApplicantsKatayoun Zomorodi
ExaminesSCHMITT, MICHAEL J
Art Unit1629
Technology Center1600
Assignments
Axsome Therapeutics Inc.
Current
Axsome Malta Ltd.Axsome Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.